| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.6 |